HeimBiotek
The First
The Best
The Frontier of Early Cancer Dx
Innovating MDx with IPs
HeimBiotek developed a highly accurate molecular diagnostic technique for diagnosis of early to late-stage cancer with liquid biopsy using whole blood, urine etc. based on miRNA detection and analysis technology, ahead of its commercialization.
Global
Innovation
R&D Initiatives & Advancement
For Global Leadership in MDx
Driving R&D and Innovation to address the unmet needs of Liquid Biopsy Cancer Diagnostics, starting with Liver Cancer.
Technology
MicroRNA
miRNA Biomarker
Next-Generation Biomarker for Early Dx Introducing an innovative diagnostic method for Cancer, Encephalopathy, Cardiovascular Diseases etc.
Technology
miRNA Detection
Detection and analysis technique to quantify miRNA using Real-Time PCR that demonstrates high sensitivity and accuracy.